Save your place

Sign in to WhoBought

Please try again later.

Lyra Therapeutics, Inc. (LYRA) institutional ownership

Latest close $0.52 Jul 17, 2026
Market cap$2.3M 52-week range $0.52 - $0.52 SectorHealthcare
Funds holding · Q1 2026
21
reported LYRA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 21 sellers

Lyra Therapeutics, Inc. (LYRA) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 21 investors
Sabby Management, LLCIkarian Capital, LLC +19 more
Bought Sold Totals per quarter; hover a bar for the names.

Lyra Therapeutics, Inc. (LYRA) institutional activity · 21

Investor Type Est. change Change Δ Own Date
Sabby Management, LLC · Reduced
Change −71K Date Q1 2026
Sabby Management, LLC Reduced· Q1 2026 −71K Q1 2026
Ikarian Capital, LLC · Exited
Change −21K Δ Own −100.0% Date Q1 2026
Ikarian Capital, LLC Exited· Q1 2026 −21K −100.0% Q1 2026
Drw Securities, LLC · Exited
Change −17K Δ Own −100.0% Date Q1 2026
Drw Securities, LLC Exited· Q1 2026 −17K −100.0% Q1 2026
Geode · Exited
Change −12K Δ Own −100.0% Date Q1 2026
Geode Exited· Q1 2026 −12K −100.0% Q1 2026
Artia Global Partners LP · Exited
Change −9K Δ Own −100.0% Date Q1 2026
Artia Global Partners LP Exited· Q1 2026 −9K −100.0% Q1 2026
BlackRock · Exited
Change −2K Δ Own −100.0% Date Q1 2026
BlackRock Exited· Q1 2026 −2K −100.0% Q1 2026
Tower Research Capital LLC (trc) · Exited
Change −2K Δ Own −100.0% Date Q1 2026
Tower Research Capital LLC (trc) Exited· Q1 2026 −2K −100.0% Q1 2026
Royal Bank of Canada · Exited
Change −2K Δ Own −100.0% Date Q1 2026
Royal Bank of Canada Exited· Q1 2026 −2K −100.0% Q1 2026
UBS Group AG · Exited
Change −675 Δ Own −100.0% Date Q1 2026
UBS Group AG Exited· Q1 2026 −675 −100.0% Q1 2026
Eversource Wealth Advisors, LLC · Exited
Change −338 Δ Own −100.0% Date Q1 2026
Eversource Wealth Advisors, LLC Exited· Q1 2026 −338 −100.0% Q1 2026
Morgan Stanley · Exited
Change −334 Δ Own −100.0% Date Q1 2026
Morgan Stanley Exited· Q1 2026 −334 −100.0% Q1 2026
Jones Financial Companies Lllp · Exited
Change −210 Δ Own −100.0% Date Q1 2026
Jones Financial Companies Lllp Exited· Q1 2026 −210 −100.0% Q1 2026
Bank of America Corp · Exited
Change −201 Δ Own −100.0% Date Q1 2026
Bank of America Corp Exited· Q1 2026 −201 −100.0% Q1 2026
Sbi Securities Co., Ltd. · Exited
Change −80 Δ Own −100.0% Date Q1 2026
Sbi Securities Co., Ltd. Exited· Q1 2026 −80 −100.0% Q1 2026
JPMorgan Chase & Co · Exited
Change −27 Δ Own −100.0% Date Q1 2026
JPMorgan Chase & Co Exited· Q1 2026 −27 −100.0% Q1 2026
Data through Q1 2026 · filed May 27, 2026
15 of 21

Famous investor activity in Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. (LYRA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Smith W. Bradford · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -640
Owned 0 Trade date May 14, 2026 Filed date May 15, 2026
Smith W. Bradford Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -640 0 May 14, 2026 May 15, 2026
Palasis Maria · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -2K
Owned 1.1M Trade date Apr 1, 2026 Filed date Apr 3, 2026
Palasis Maria Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -2K 1.1M Apr 1, 2026 Apr 3, 2026
Cavalier Jason · Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -667
Owned 518K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Cavalier Jason Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -667 518K Apr 1, 2026 Apr 3, 2026
Cavalier Jason · Officer Sell −$3K
Price $3.36 Qty −769 Owned 519K Trade date Jan 6, 2026 Filed date Jan 8, 2026
Cavalier Jason Officer Sell $3.36 −769 −$3K 519K Jan 6, 2026 Jan 8, 2026
Palasis Maria · Director, Officer Sell −$6K
Price $3.36 Qty −2K Owned 1.1M Trade date Jan 6, 2026 Filed date Jan 8, 2026
Palasis Maria Director, Officer Sell $3.36 −2K −$6K 1.1M Jan 6, 2026 Jan 8, 2026
Perceptive Advisors LLC · 10% Owner 2 operations −$124K
Price $3.90 Qty −32K Owned 14K Trade date Nov 13, 2025 Filed date Nov 13, 2025
Perceptive Advisors LLC 10% Owner 2 operations $3.90 −32K −$124K 14K Nov 13, 2025 Nov 13, 2025
Perceptive Advisors LLC · 10% Owner 2 operations −$36K
Price $4.06 Qty −9K Owned 153K Trade date Nov 12, 2025 Filed date Nov 13, 2025
Perceptive Advisors LLC 10% Owner 2 operations $4.06 −9K −$36K 153K Nov 12, 2025 Nov 13, 2025
Perceptive Advisors LLC · 10% Owner 2 operations −$23K
Price $4.31 Qty −5K Owned 161K Trade date Nov 11, 2025 Filed date Nov 13, 2025
Perceptive Advisors LLC 10% Owner 2 operations $4.31 −5K −$23K 161K Nov 11, 2025 Nov 13, 2025
Edelman Joseph · 10% Owner 2 operations −$84K
Price $4.54 Qty −19K Owned 166K Trade date Nov 10, 2025 Filed date Nov 10, 2025
Edelman Joseph 10% Owner 2 operations $4.54 −19K −$84K 166K Nov 10, 2025 Nov 10, 2025
Edelman Joseph · 10% Owner 2 operations −$94K
Price $4.75 Qty −20K Owned 183K Trade date Nov 7, 2025 Filed date Nov 10, 2025
Edelman Joseph 10% Owner 2 operations $4.75 −20K −$94K 183K Nov 7, 2025 Nov 10, 2025
Edelman Joseph · 10% Owner 2 operations −$167K
Price $5.18 Qty −32K Owned 23K Trade date Nov 6, 2025 Filed date Nov 10, 2025
Edelman Joseph 10% Owner 2 operations $5.18 −32K −$167K 23K Nov 6, 2025 Nov 10, 2025
Palasis Maria · Director, Officer Grant (A) 4K
Owned 7K Trade date Oct 1, 2025 Filed date Oct 3, 2025
Palasis Maria Director, Officer Grant (A) 4K 7K Oct 1, 2025 Oct 3, 2025
12 of 12

Lyra Therapeutics, Inc. (LYRA) activist and large shareholders

Dates
No Schedule 13D or 13G filing is available for LYRA in this range.

Lyra Therapeutics, Inc. (LYRA) ownership FAQ

Who owns LYRA?

21 reporting institutions disclosed LYRA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.